학술논문
The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial
Document Type
Article
Author
Source
In The Lancet Rheumatology March 2022 4(3):e208-e219
Subject
Language
ISSN
2665-9913